-4.38%
Today
Loading 1D prices…
Company profile
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Sector
Health Care
Industry
Medicinal Chemicals & Botanical Products
Exchange
Nasdaq
Display currency
USD
Location
Yavne, Israel, United States
Employees
121
Fiscal year end
1231
CIK
1593984
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ACBAurora Cannabis Inc. Common Shares | $236.8M | — | — | -$2.14 | +0.08% | Buy |
| NAGENiagen Bioscience Inc. Common Stock | $240.5M | $129.4M | +13.43% | $0.20 | -0.16% | Buy |
| USNAUSANA Health Sciences Inc. Common Stock | $277.5M | $925.3M | +1.16% | $0.58 | +1.35% | Sell |
| SNDLSNDL Inc. Common Shares | $329.8M | — | — | -$0.06 | +0.00% | Hold |
| FTLFFitLife Brands Inc. Common Stock | $86.5M | $81.5M | +7.77% | $0.20 | +1.25% | Buy |